148 related articles for article (PubMed ID: 17252017)
1. Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.
O'Neill KL; Zhang F; Li H; Fuja DG; Murray BK
Leukemia; 2007 Mar; 21(3):560-3. PubMed ID: 17252017
[No Abstract] [Full Text] [Related]
2. Clinical and biological significance of serum tumor markers in adult T-cell leukemia.
Sadamori N
Leuk Lymphoma; 1996 Aug; 22(5-6):415-9. PubMed ID: 8882954
[TBL] [Abstract][Full Text] [Related]
3. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO).
Iwata H; Kami M; Kishi Y; Oki Y; Tanaka Y; Takeuchi K; Yamazaki I; Suzuki R; Morinaga S; Mutou Y
Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040
[No Abstract] [Full Text] [Related]
4. Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia.
Sadamori N; Ichiba M; Mine M; Hakariya S; Hayashibara T; Itoyama T; Nakamura H; Tomonaga M; Hayashi K
Br J Haematol; 1995 May; 90(1):100-5. PubMed ID: 7786770
[TBL] [Abstract][Full Text] [Related]
5. Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia.
Blink M; Buitenkamp TD; van den Heuvel-Eibrink MM; Danen-van Oorschot AA; de Haas V; Reinhardt D; Klusmann JH; Zimmermann M; Devidas M; Carroll AJ; Basso G; Pession A; Hasle H; Pieters R; Rabin KR; Izraeli S; Zwaan CM
Leukemia; 2011 Aug; 25(8):1365-8. PubMed ID: 21537335
[No Abstract] [Full Text] [Related]
6. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
7. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and DIC in acute leukaemia.
Guarini A; Gugliotta L; Bianchi A; De Groote D; Foa R
Eur J Haematol; 1990 Aug; 45(2):121-2. PubMed ID: 2209819
[No Abstract] [Full Text] [Related]
9. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
[No Abstract] [Full Text] [Related]
10. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
11. Adult acute leukemia.
Cripe LD
Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
[TBL] [Abstract][Full Text] [Related]
12. Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Albitar M; Johnson M; Do KA; Day A; Jilani I; Pierce S; Estey E; Kantarjian H; Keating M; Verstovsek S; O'brien S; Giles FJ
Leukemia; 2007 Mar; 21(3):480-8. PubMed ID: 17215857
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments.
Mueller S; Holdenrieder S; Stieber P; Haferlach T; Schalhorn A; Braess J; Nagel D; Seidel D
BMC Cancer; 2006 May; 6():143. PubMed ID: 16734907
[TBL] [Abstract][Full Text] [Related]
14. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.
Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A
Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.
Vinante F; Rigo A; Tecchio C; Morosato L; Nadali G; Ricetti MM; Krampera M; Zanolin E; Locatelli F; Gallati H; Chilosi M; Pizzolo G
Br J Haematol; 1998 Sep; 102(4):1025-34. PubMed ID: 9734654
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.
List AF; Spier CS; Grogan TM; Johnson C; Roe DJ; Greer JP; Wolff SN; Broxterman HJ; Scheffer GL; Scheper RJ; Dalton WS
Blood; 1996 Mar; 87(6):2464-9. PubMed ID: 8630412
[TBL] [Abstract][Full Text] [Related]
17.
Byun JM; Koh Y; Shin DY; Kim I; Yoon SS; Lee JO; Bang SM; Kim KH; Jung SH; Lee WS; Park Y; Jang JH; Han JJ; Yhim HY; Kim DS; Lee YJ; Lee H; Choi YS; Lee S;
Haematologica; 2017 May; 102(5):e187-e190. PubMed ID: 28082339
[No Abstract] [Full Text] [Related]
18. SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.
Mu Q; Guo L; Hu Y; Sheng L; Zhang Y; Wu N; Chen Y; Shi C; Shi S; Wu Y; Ouyang G
Leuk Lymphoma; 2017 Sep; 58(9):1-3. PubMed ID: 28278724
[No Abstract] [Full Text] [Related]
19. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy.
Naoe T; Tagawa Y; Kiyoi H; Kodera Y; Miyawaki S; Asou N; Kuriyama K; Kusumoto S; Shimazaki C; Saito K; Akiyama H; Motoji T; Nishimura M; Shinagawa K; Ueda R; Saito H; Ohno R
Leukemia; 2002 Feb; 16(2):203-8. PubMed ID: 11840286
[TBL] [Abstract][Full Text] [Related]
20. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
